Inceptor Bio company information, Employees & Contact Information

Inceptor Bio doses first subject in trial of IB-T101 for renal cell carcinoma Clinical Trials Arena

Inceptor Bio partners with Grit Bio to advance CAR T therapy BioWorld MedTech

Cell therapy weekly: world’s first hospital-based autologous foundry RegMedNet

Inceptor Bio Announces $37 Million Series A Financing to Develop Cell Therapies for Difficult-to-Treat Cancers PR Newswire

Inceptor Bio to use $37M series A to nudge CAR-T toward clinic, establish manufacturing base Fierce Biotech

Cyclana Bio raises funding to advance approach to endometriosis BioWorld MedTech

RTP cell therapy firm names new CEO The Business Journals

Inceptor binds to and directs insulin towards lysosomal degradation in β cells Nature

Inceptor Bio snaps up Arranta Bio manufacturing site as it preps to move preclinical cell therapies forward Fierce Pharma

Kincell Bio Launches with $36M to Make Cell Therapy GlobeNewswire

Kincell spins out of cell therapy biotech, joining wave of manufacturing startups BioPharma Dive

Inceptor partners to improve CAR-T production - BioProcess Insider BioProcess International

Inceptor Bio Launches Next-Generation CAR-T, CAR-M, and NK/NKT Platform Focused on Advancing Cell and Gene Therapies to Cure Difficult-To-Treat Cancers PR Newswire

Inceptor: building persistence of cancer cell therapies BioCentury

While Auto vs. Allo Cell Therapy Debate Continues, VCs Look for ‘Next Shiny Thing’ MedCity News

In Your Head: Ori Biotech Is Designing Modules for Scalable Cell Therapy Manufacturing Genetic Engineering and Biotechnology News

Inceptor, Avectas are latest biotechs to take up solid tumor CAR-T challenge Fierce Biotech

Inceptor Bio Launches FastBack Bio, Its First Portfolio Company Developing A Novel CAR-T Platform That Targets Difficult-To-Treat Cancers PR Newswire

Arranta Bio Announces Completion of Sale of Florida Site and Progress on $150M Investment Plan to Expand Development and Commercial Manufacturing Services PR Newswire

Kincell Bio Launches to Make Cell Therapy Development More Accessible Contract Pharma

Inceptor loss in mice with obesity Nature

Global, neuronal or β cell-specific deletion of inceptor improves glucose homeostasis in male mice with diet-induced obesity Nature

Inceptor facilitates acrosomal vesicle formation in spermatids and is required for male fertility Frontiers

Kyowa joins GSK in Tim-3 | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Inceptor as a regulator of brain insulin sensitivity Nature

Inceptor counteracts insulin signalling in β-cells to control glycaemia Nature

FDA granted Fast Track to Allogene’s ALLO-605 to treat relapsed or refractory multiple myeloma PPF Group

Cell therapy CDMO Kincell Bio launches with $36m infusion Pharmaceutical Business review -

Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers Fierce Biotech

The top biotech hubs in 2022 Fierce Biotech

Arranta Bio splashes $100M into 'microbiome' CDMO capacity with new Massachusetts facility Fierce Pharma

Inceptor Binds Excess Insulin and Directs It Toward Degradation Genetic Engineering and Biotechnology News

Skyepharma inks deal to build largest microbiome facility in France Fierce Pharma

Big Pharma partnerships, record $22.7B investment raise profile of regenerative medicine in 2021 Fierce Biotech

CAR-T countdown: NeoImmuneTech drug could reduce number of cells needed for cancer therapy fivefold Fierce Biotech

Starry syndicate powers $165M bet on in vivo CAR-T therapies, enabling Penn spinout Capstan to set sail Fierce Biotech

How Cell and Gene Therapy Manufacturing Will Evolve in 2024 BioSpace

Taking Charge—biotechs already approaching Novartis to partner on 'game changing' CAR-T platform Fierce Biotech

CAR-T Funding Report 2025 | Over 1,944 CAR-T Therapies in Development as Global Collaborations Reach New Heights - ResearchAndMarkets.com Business Wire

UNC-Chapel Hill technology brought the school a record amount of money in the past year Raleigh News & Observer

J&J refuels CAR-T ambitions with $245M upfront to Cellular Biomedicine for pair of therapies Fierce Biotech

Rivers • The Interceptor The Ocean Cleanup

Sixfold raises $10.5M to advance targeted mRNA therapies BioWorld MedTech

Eyes on the prize: Aurion Biotech raises $120M for 'global transformation in the cornea' Fierce Biotech

[SHOT 2024] Inceptor Ammunition Delivers on the Reloading Market with Component Bullets thefirearmblog.com

The Interceptor (TV Mini Series 2015) ⭐ 6.2 | Crime, Drama IMDb

Fly-By-Wire Inceptor for Evtol Aircraft Bisinfotech

Testing G2 R.I.P., Liberty Civil Defense, Inceptor, and Lehigh Defense Rounds – Part 6 – Conclusions thefirearmblog.com